Abstract
We have constructed a high-resolution genomic microarray of human chromosome 16q, and used it for comparative genomic hybridization analysis of 16 prostate tumors. We demarcated 10 regions of genomic loss between 16q23.1 and 16qter that occurred in five or more samples. Mining expression array data from four independent studies allowed us to identify 11 genes that were frequently underexpressed in prostate cancer and that co-localized with a region of genomic loss. Quantitative expression analyses of these genes in matched tumor and benign tissue from 13 patients showed that six of these 11 (WWOX, WFDC1, MAF, FOXF1, MVD and the predicted novel transcript Q9H0B8 (NM_031476)) had significant and consistent downregulation in the tumors relative to normal prostate tissue expression making them candidate tumor suppressor genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ and Aldaz CM . (2001). Cancer Res., 61, 8068–8073.
Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Paez I, Diaz De Stahl T, Rosenquist M, Ali H, Jarbo C, De Bustos C, Hirvela C, Sinder Wilen B, Fransson I, Thyr C, Johnsson BI, Bruder CE, Menzel U, Hergersberg M, Mandahl N, Blennow E, Wedell A, Beare DM, Collins JE, Dunham I, Albertson D, Pinkel D, Bastian BC, Faruqi AF, Lasken RS, Ichimura K, Collins VP and Dumanski JP . (2002). Hum. Mol. Genet., 11, 3221–3229.
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T and Kuehl WM . (1998). Blood, 91, 4457–4463.
Chu LW, Troncoso P, Johnston DA and Liang JC . (2003). Genes Chromosomes Cancer, 36, 303–312.
Collins C, Volik S, Kowbel D, Ginzinger D, Ylstra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo WL, Alberts A and Gray JW . (2001). Genome Res., 11, 1034–1042.
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM . (2001). Nature, 412, 822–826.
Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O and Vihko P . (1999). Br. J. Cancer, 79, 156–160.
Giese A, Jude R, Kuiper H, Raudsepp T, Piumi F, Schambony A, Guerin G, Chowdhary BP, Distl O, Topfer-Petersen E and Leeb T . (2002). Gene, 299, 101–109.
Hale TK, Myers C, Maitra R, Kolzau T, Nishizawa M and Braithwaite AW . (2000). J. Biol. Chem., 275, 17991–17999.
Han CS, Sutherland RD, Jewett PB, Campbell ML, Meincke LJ, Tesmer JG, Mundt MO, Fawcett JJ, Kim UJ, Deaven LL and Doggett NA . (2000). Genome Res., 10, 714–721.
Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, Moore D, Albertson DG, Pinkel D, Collins C, Hanahan D and Gray JW . (2001). Nat. Genet., 29, 459–464.
Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG and Pinkel D . (2002). Genome Res., 12, 325–332.
Kochetkova M, McKenzie OLD, Bais AJ, Martin JM, Secker GA, Seshadri R, Powell JA, Hinze SJ, Gardner AE, Spendlove HE, O'Callaghan NJ, Cleton-Jansen A-M, Cornelisse C, Whitmore SA, Crawford J, Kremmidiotis G, Sutherland GR and Callen DF . (2002). Cancer Res., 62, 4599–4604.
Larsen M, Ressler SJ, Lu B, Gerdes MJ, McBride L, Dang TD and Rowley DR . (1998). J. Biol. Chem., 273, 4574–4584.
Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM and Isaacs WB . (2001). Cancer Res., 61, 4683–4688.
Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA and Milbrandt J . (2001). Cancer Res., 61, 5692–5696.
Mahlapuu M, Enerback S, Carlsson P, Wadhwa R, Yaguchi T, Hasan MK, Taira K and Kaul SC . (2001). Development, 128, 2397–2406.
Matsuyama H, Pan Y, Yoshihiro S, Kudren D, Naito K, Bergerheim US and Ekman P . (2003). Prostate, 54, 103–111.
Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ and Watson JE . (2000). Cancer Res., 60, 1690–1697.
Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H and Watson JE . (2001). Proc. Natl. Acad. Sci. USA, 98, 11417–11422.
Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schroder FH, Vissers KJ, Watson VJ, Wildhagen MF, Collins C and Van Dekken H . (2003). Am. J. Pathol., 162, 763–770.
Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ and Casey G . (2000). Cancer Res., 60, 3645–3649.
Rhodes DR, Barrette TR, Rubin MA, Ghosh D and Chinnaiyan AM . (2002). Cancer Res., 62, 4427–4433.
Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E and Richards RI . (2000). Hum. Mol. Genet., 9, 1651–1663.
Rowley DR, Dang TD, Larsen M, Gerdes MJ, McBride L and Lu B . (1995). J. Biol. Chem., 270, 22058–22065.
Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers MJ, Debruyne FM, Ruiter DJ and Schalken JA . (1999). J. Pathol., 188, 271–277.
Smith DM, Collins-Racie LA, Marigo VA, Roberts DJ, Davis NM, Hartmann C, Schweitzer R, LaVallie ER, Gamer L, McCoy J and Tabin CJ . (2001). Mech. Dev., 102, 223–226.
Strup SE, Pozzatti RO, Florence CD, Emmert-Buck MR, Duray PH, Liotta LA, Bostwick DG, Linehan WM and Vocke CD . (1999). J. Urol., 162, 590–594.
Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD and Gazdar AF . (2001). Cancer Res., 61, 4556–4560.
Van Dekken H, Krijtenburg PJ and Alers JC . (2000). Acta Histochem, 102, 85–94.
Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA and Schalken JA . (2003). Prostate, 54, 50–57.
Wadhwa R, Yaguchi T, Hasan MK, Taira K and Kaul SC . (2003). Biochem. Biophys. Res. Commun., 302, 735–742.
Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson Jr HF and Hampton GM . (2001). Cancer Res., 61, 5974–5978.
Acknowledgements
We thank Graeme Hodgson and Eric Gagne for advice, Maime Yu, Marcella Fasso, Ajay Jain and Jane Fridlyand for technical assistance, Karen Taylor for supplying PAC clones, Terrence Barrette for expression array data, and Peter Carroll and Karen Chew for patient material. This work was supported by the National Cancer Institute (Prostate Cancer SPORE Grant CA89520).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vivienne Watson, J., Doggett, N., Albertson, D. et al. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23–qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 23, 3487–3494 (2004). https://doi.org/10.1038/sj.onc.1207474
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207474
Keywords
This article is cited by
-
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients
The Pharmacogenomics Journal (2018)
-
FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor
Oncogene (2017)
-
MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1
Oncogene (2014)
-
Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness
Oncogene (2014)
-
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma
Clinical & Experimental Metastasis (2009)